Skip to main content
SpringerLink
Log in

Salvage-Radiotherapie mit oder ohne Kurzzeit-Antihormonbehandlung beim PSA-Rezidiv

Salvage radiotherapy with or without short-term hormone suppression for rising PSA levels

  • Literatur kommentiert
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Roach M III (2014) Current trends for the use of androgen deprivation therapy in conjunction with radiotherapy for patients with unfavorable intermediate-risk, high-risk, localized, and locally advanced prostate cancer. Cancer 120:1620–1629

    Article  CAS  PubMed  Google Scholar 

  2. Hermann RM, Schwarten D, Fister S et al (2007) No supra-additive effects of goserelin and radiotherapy on clonogenic survival of prostate carcinoma cells in vitro. Radiat Oncol 2:31

    Article  PubMed  PubMed Central  Google Scholar 

  3. Shipley WU, Pugh SL, Lukka HR et al (2016) RTOG 9601, a phase III trial in prostate cancer patients: Anti-androgen therapy (AAT) with bicalutamide during and after salvage radiation therapy (RT) following radical prostatectomy (RP) and an elevated PSA. J Clin Oncol 34(suppl. 2):abstr. 3

    Google Scholar 

  4. https://clinicaltrials.gov/ct2/show/NCT00949962. Zugegriffen: 2. Juli 2016

  5. https://www.auanet.org/university/abstract_detail.cfm?id=955&meetingID=12ATL. Zugegriffen: 2. Juli 2016

  6. https://clinicaltrials.gov/ct2/show/NCT00567580. Zugegriffen: 2. Juli 2016

  7. http://www.radicals-trial.org/. Zugegriffen: 2. Juli 2016

  8. Ghadjar P, Hayoz S, Bernhard J et al (2015) Acute toxicity and quality of life after dose-intensified salvage radiation therapy for biochemically recurrent prostate cancer after prostatectomy: first results of the randomized trial SAKK 09/10. J Clin Oncol 33:4158–4166

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Zentrum für Strahlentherapie und Radioonkologie, Mozartstr. 30, 26655, Westerstede, Deutschland

    R. M. Hermann

  2. Klinik für Strahlentherapie und Spezielle Onkologie, Medizinische Hochschule Hannover, Hannover, Deutschland

    H. Christiansen

Authors
  1. R. M. Hermann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Christiansen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. M. Hermann.

Ethics declarations

Interessenkonflikt

R. M. Hermann und H. Christiansen geben an, dass kein Interessenkonflikt besteht.

Additional information

Originalpublikation Carrie C, Hasbini A, de Laroche G et al (2016) Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial. Lancet Oncol 17(6):747–756

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hermann, R.M., Christiansen, H. Salvage-Radiotherapie mit oder ohne Kurzzeit-Antihormonbehandlung beim PSA-Rezidiv. Strahlenther Onkol 192, 741–744 (2016). https://doi.org/10.1007/s00066-016-1032-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-016-1032-6

Search

Navigation